ES2176500T3 - Vectores retroviricos que llevan inhibidores 1 derivados de celulas senescentes (sdi-1) o secuencias de nucleotidos antisentido de sdi-1. - Google Patents

Vectores retroviricos que llevan inhibidores 1 derivados de celulas senescentes (sdi-1) o secuencias de nucleotidos antisentido de sdi-1.

Info

Publication number
ES2176500T3
ES2176500T3 ES96934660T ES96934660T ES2176500T3 ES 2176500 T3 ES2176500 T3 ES 2176500T3 ES 96934660 T ES96934660 T ES 96934660T ES 96934660 T ES96934660 T ES 96934660T ES 2176500 T3 ES2176500 T3 ES 2176500T3
Authority
ES
Spain
Prior art keywords
sequences
sdi
retroviric
vectors carrying
nucleotid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96934660T
Other languages
English (en)
Inventor
Walter H Gunzburg
Robert Michael Saller
Brian Salmons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Austrian Nordic Biotherapeutics AG
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Austrian Nordic Biotherapeutics AG
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austrian Nordic Biotherapeutics AG, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Austrian Nordic Biotherapeutics AG
Application granted granted Critical
Publication of ES2176500T3 publication Critical patent/ES2176500T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A VECTORES RETROVIRICOS PORTADORES DE SECUENCIAS DE ADN QUE CODIFICAN SDI-1, FRAGMENTOS O ANALOGOS FUNCIONALES DE ESTOS, O SECUENCIAS DE ADN SDI-1 ANTISENTIDO, Y ESPECIALMENTE VECTORES RETROVIRICOS PORTADORES DE SECUENCIAS SDI-1 O SECUENCIAS SDI-1 ANTISENTIDO BAJO CONTROL DE TRANSCRIPCION DE ELEMENTOS REGULADORES ESPECIFICOS O PROMOTORES DE LA CELULA DIANA O DE PROMOTORES INDUCIBLES POR RAYOS X.
ES96934660T 1995-10-13 1996-10-11 Vectores retroviricos que llevan inhibidores 1 derivados de celulas senescentes (sdi-1) o secuencias de nucleotidos antisentido de sdi-1. Expired - Lifetime ES2176500T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK115795 1995-10-13

Publications (1)

Publication Number Publication Date
ES2176500T3 true ES2176500T3 (es) 2002-12-01

Family

ID=8101648

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96934660T Expired - Lifetime ES2176500T3 (es) 1995-10-13 1996-10-11 Vectores retroviricos que llevan inhibidores 1 derivados de celulas senescentes (sdi-1) o secuencias de nucleotidos antisentido de sdi-1.

Country Status (7)

Country Link
EP (1) EP0859854B1 (es)
AT (1) ATE217023T1 (es)
AU (1) AU7291696A (es)
DE (1) DE69621035T2 (es)
DK (1) DK0859854T3 (es)
ES (1) ES2176500T3 (es)
WO (1) WO1997013867A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6139817A (en) * 1996-10-15 2000-10-31 Smithkline Beecham Corporation Method for determining gene essentiality in a pathogen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302706A (en) * 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
EP0723402B1 (en) * 1993-08-30 2010-08-18 Baylor College Of Medicine Senescent cell-derived inhibitors of dna synthesis
WO1995013375A1 (en) * 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1
JP4037446B2 (ja) * 1994-09-02 2008-01-23 ゲーエスエフ − フォルシュンクスツェントルム・フューア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 非自己不活化性の発現標的化レトロウイルスベクタ
US5863904A (en) * 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21

Also Published As

Publication number Publication date
WO1997013867A1 (en) 1997-04-17
EP0859854B1 (en) 2002-05-02
EP0859854A1 (en) 1998-08-26
ATE217023T1 (de) 2002-05-15
DE69621035D1 (de) 2002-06-06
DK0859854T3 (da) 2002-08-19
AU7291696A (en) 1997-04-30
DE69621035T2 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
ATE521718T1 (de) Prozess zur synthetisierung von nukleinsäure
PT1222292E (pt) Metodo para regulacao da transcricao de genes exogenos na presenca de azoto
ATE320500T1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
DK0397269T3 (da) Fremgangsmåde til syntese af ribonukleinsyre (RNA)
DK0857211T3 (da) Stærk homolog promoter fra hamster
DK0632831T3 (da) Nukleinsyre, ekspressionsvektor og sammensætninger til identificering og syntese af rekombinante sialyltransferaser
AU5720498A (en) Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
DE69829857D1 (de) Hypoxie-regulierte gene
ATE495255T1 (de) Identifikation des gens das zum schorfigen phenotyp der maus führt, sowie seines menschlichen orthologs
ATE228567T1 (de) Transformation von phaffia rhodozyma
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
ATE91715T1 (de) Genexpressionssystem.
ES2176500T3 (es) Vectores retroviricos que llevan inhibidores 1 derivados de celulas senescentes (sdi-1) o secuencias de nucleotidos antisentido de sdi-1.
ES2124694T3 (es) Clonacion de la n-metil-hidantoinasa.
ATE311471T1 (de) Bindung mehrerer zinkfinger transkriptionsfaktoren an nukleinsäuren
ATE89005T1 (de) Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
ATE296835T1 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
ATE500338T1 (de) Verwendung des adenoviralen e2-late-promotors
NO20001404D0 (no) Nye stereoselektive fremgangsmåter for fremstilling av gabapentinanaloger
AU3081500A (en) Dna oligonucleotide which is specific for meloidogyne species, dna vector and host cell containing the oligonucleotide, use and kit
DE69637429D1 (de) Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert
DE60032162D1 (de) Regulatorische sequenzen von funktioneller bedeutung in filamentösen pilzen
EP1050580A4 (en) NUCLEIC ACID FRAGMENTS, RECOMBINANT VECTORS, WHICH CONTAIN THESE AND METHODS TO SUPPORT THE EXPRESSION OF STRUCTURAL GENES BY APPLICATION THEREOF
IL148117A0 (en) Dihydroorotase extracted from plants
IT1276724B1 (it) Vettore plasmidico di espressione per cellule di mammifero